Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ccx282-b
2. Gsk1605786a
3. Traficet-en
1. 698394-73-9
2. Traficet-en
3. Ccx282-b
4. Gsk1605786
5. Gsk-1605786
6. 4-(2-((4-(tert-butyl)phenyl)sulfonamido)-5-chlorobenzoyl)pyridine 1-oxide
7. 4-tert-butyl-n-[4-chloro-2-(1-oxidopyridin-1-ium-4-carbonyl)phenyl]benzenesulfonamide
8. Benzenesulfonamide, N-(4-chloro-2-((1-oxido-4-pyridinyl)carbonyl)phenyl)-4-(1,1-dimethylethyl)-
9. Benzenesulfonamide, N-[4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl]-4-(1,1-dimethylethyl)-
10. Vercirnon [inn]
11. Vercirnon [usan]
12. Vercirnon [who-dd]
13. Mwi54oua12
14. Schembl342225
15. Gtpl9046
16. Chembl2178578
17. Ccx-282-b
18. Dtxsid50220135
19. Gsk'786
20. Ycb39473
21. Bdbm50398334
22. Zinc38562120
23. Cs-4963
24. Db15250
25. Ncgc00485483-01
26. Da-22939
27. Gsk-1605786;ccx282-b
28. Hy-15724
29. Ft-0735140
30. A914682
31. Q27089138
32. 4-(2-(4-tert-butylphenylsulfonamido)-5-chlorobenzoyl)pyridine 1-oxide
33. 4-tert-butyl-n-[4-chloro-2-(1-oxidoisonicotinoyl)phenyl]benzenesulfonamide
| Molecular Weight | 444.9 g/mol |
|---|---|
| Molecular Formula | C22H21ClN2O4S |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 444.0910560 g/mol |
| Monoisotopic Mass | 444.0910560 g/mol |
| Topological Polar Surface Area | 97.1 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 687 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Vercirnon, a small molecule, orally-available drug, is intended to control the inappropriate immune system response underlying IBD by blocking the activity of the CCR9 chemokine receptor. In adults, CCR9 is a highly specific receptor expressed by T cells that migrate selectively to the digestive tract. The trafficking of T cells to the small and large intestine causes persistent inflammation that may result in Crohn's disease or ulcerative colitis - the two principal forms of IBD.
ABOUT THIS PAGE
65
PharmaCompass offers a list of Vercirnon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vercirnon manufacturer or Vercirnon supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vercirnon manufacturer or Vercirnon supplier.
PharmaCompass also assists you with knowing the Vercirnon API Price utilized in the formulation of products. Vercirnon API Price is not always fixed or binding as the Vercirnon Price is obtained through a variety of data sources. The Vercirnon Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vercirnon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vercirnon, including repackagers and relabelers. The FDA regulates Vercirnon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vercirnon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vercirnon supplier is an individual or a company that provides Vercirnon active pharmaceutical ingredient (API) or Vercirnon finished formulations upon request. The Vercirnon suppliers may include Vercirnon API manufacturers, exporters, distributors and traders.
Vercirnon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vercirnon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vercirnon GMP manufacturer or Vercirnon GMP API supplier for your needs.
A Vercirnon CoA (Certificate of Analysis) is a formal document that attests to Vercirnon's compliance with Vercirnon specifications and serves as a tool for batch-level quality control.
Vercirnon CoA mostly includes findings from lab analyses of a specific batch. For each Vercirnon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vercirnon may be tested according to a variety of international standards, such as European Pharmacopoeia (Vercirnon EP), Vercirnon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vercirnon USP).
